JNMT
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shih, W.-J.
Right arrow Articles by Wierzbinski, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shih, W.-J.
Right arrow Articles by Wierzbinski, B.
Journal of Nuclear Medicine Technology Volume 29, Number 2, 2001 84-85
© 2001 by Society of Nuclear Medicine


IMAGING

Localization of 99mTc HMDP in an Extraskeletal Myxoid Chondrosarcoma: A Case Report

Wei-Jen Shih, Bonnie Mitchell, Sylvia Magoun and Becky Wierzbinski

Nuclear Medicine Service and Pathology Service, Lexington VA Medical Center, Division of Nuclear Medicine, Department of Diagnostic Radiology, and Department of Pathology, University of Kentucky Medical Center, Lexington, Kentucky

Extraskeletal myxoid chondrosarcoma of the lower extremity is rare, and slowly progressive. The authors of this article present the case of a man with progressive enlargement of the right thigh that underwent bone scintigraphy. The bone images showed a diffuse, moderate increase in uptake in the swollen right thigh. Despite chemotherapy, the patient died 28 mo later. At autopsy, it was confirmed that he had extraskeletal myxoid chondrosarcoma of the right thigh, which had metastasized to the upper arms, left scapula, lungs, pleurae, and right lower quadrant of the abdomen. The myxoid chondroid matrix, a major feature of the extraskeletal myxoid chondrosarcoma, is thought to account for the localization of the bone-imaging agent.

Key Words: myxoid chondrosarcoma; bone-imaging agent; 99mTc HMDP; lower extremity







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
THE JOURNAL OF NUCLEAR MEDICINE JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY
Copyright © 2001 by the Society of Nuclear Medicine Technologist Section.